Skip to main content

Day: January 24, 2022

Walker Covey Wealth Advisors Launches With Support of LPL Strategic Wealth Services

CHARLOTTE, N.C., Jan. 24, 2022 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) today announced that financial advisors Andy Walker and Christian Covey have launched a new practice, Walker Covey Wealth Advisors, through affiliation with LPL Strategic Wealth Services model. Previously, the advisors were part of a firm working with approximately $350 million in advisory, brokerage and retirement plan assets.* They join LPL from Commonwealth. Based in Utah County, Walker and Covey are Brigham Young University graduates who teamed up to combine their strengths in order to help clients better understand their finances and investments. “Working together, we’ve built a strong trust in each other. We’re both grounded in our philosophy and systematic processes focused on principle-based investing,” said Walker, managing partner and chief...

Continue reading

Cemtrex Reports Fourth Quarter and Full Year 2021 Financial Results

Fourth Quarter Revenues Increase 37% to $14.7 Million Brooklyn, NY, Jan. 24, 2022 (GLOBE NEWSWIRE) —  – Cemtrex Inc. (NASDAQ: CETX, CETXP, CETXW), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, has reported its financial and operational results for the fourth quarter and year ended September 30, 2021. Key Fourth Quarter 2021 HighlightsLaunched the SmartDesk Connect D, a new version that extends compatibility to more devices including most mid- to high-end laptops, Apple® M1 products and select Microsoft Surface® devices. Bravo Strong has continued with the development of first VR game and expects a beta release of StarForceVR in Oculus Quest App Lab in CY22 Q1. Appointed independent directors Chris Wagner,...

Continue reading

Motorsport Games’ Le Mans Virtual Series followed by more than 81 million fans on live TV, digital streaming and social media throughout the 2021-2022 season

The series concludes its 5-month season with racing legends, millions of fans and hundreds of lapsLMVSSeason FinaleMIAMI, Jan. 24, 2022 (GLOBE NEWSWIRE) — The five-round 2021-22 Le Mans Virtual Series, which was brought to a glittering conclusion last weekend with the star-studded 24 Hours of Le Mans Virtual, registered impressive, cumulated TV and digital audience figures of more than 81 million throughout its 5-month season.  The grand finale to the Le Mans Virtual Series held on January 15 and 16, 2022 brought together 50 cars with 200 drivers hailing from 39 different countries. Racers competed on 116 simulators worldwide located in 28 countries on an extremely accurate virtual rendition of the iconic Circuit des 24 Heures in Le Mans, France. Heading a grid of famous racing names and leading the charge in...

Continue reading

CareTrust REIT, Inc. Announces Tax Treatment of 2021 Dividends

SAN CLEMENTE, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) reported today the tax status of its 2021 dividends paid to shareholders. Details on the classifications of the dividends are included in the table below:DISTRIBUTIONS ON CARETRUST COMMON STOCK          Box 1a Box 1b Box 2a Box 2b Box 3 Box 5                Unrecap.                Qualified   Section          Taxable     Dividend   1250 Gain   SectionRecord Payment Distribution Distribution   Ordinary (Included in Capital (Included in Non-Dividend 199ADate Date Per Share Per Share   Dividend Box 1a) Gain Distr. Box 2a) Distributions Dividend12/31/20 01/15/21 $ 0.2500 $ 0.2500   90.0562 % 0.0000 % 0.0000 % 0.0000 % 9.9438 % 90.0562 %03/31/21 04/15/21 $ 0.2650 $ 0.2650   90.0562 % 0.0000 % 0.0000 % 0.0000 % 9.9438 % 90.0562 %06/30/21 07/15/21 $ 0.2650 $ 0.2650   90.0562 % 0.0000 % 0.0000 % 0.0000 % 9.9438 % 90.0562 %09/30/21 10/15/21 $ 0.2650 $ 0.2650   90.0562 % 0.0000 % 0.0000 % 0.0000 % 9.9438 % 90.0562 %12/31/21 01/15/22 $ 0.2650 $ – (1 ) 0.0000 % 0.0000 % 0.0000 % 0.0000 % 0.0000 % 0.0000 %Total $ 1.3100 $ 1.0450   90.0562 % 0.0000 % 0.0000 % 0.0000 % 9.9438 % 90.0562 %(1)...

Continue reading

Udemy to Report Fourth Quarter Fiscal Year 2021 Results on February 9, 2022

SAN FRANCISCO, Jan. 24, 2022 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today announced it will release its financial results for its fourth quarter ended December 31, 2021, after market close on February 9, 2022. Udemy will host a conference call and earnings webcast beginning at 5:00 p.m. EST / 2:00 p.m. PST on the same day to discuss the company’s financial results. Interested parties may access the conference call by registering here. The conference call will also be webcast live on the Udemy Investor Relations website at https://investors.udemy.com/. Shortly after the conclusion of the live earnings call, an archived replay of the webcast will be available on the Udemy Investor Relations website at https://investors.udemy.com/. About UdemyUdemy’s (Nasdaq: UDMY) mission...

Continue reading

Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI Meeting

Interim data presented in poster reflects median overall survival of 12.0 months, not yet final, and an objective response rate of 48%, both greater than historical rates reported for standard of careMINNEAPOLIS, Jan. 24, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced the presentation of interim clinical data from its Phase 1b combination therapy study of SBP-101, a proprietary polyamine analogue, with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma (PDA), at the American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Meeting that took place January 20-22, 2022. Jennifer K. Simpson, PhD, MSN, CRNP President & Chief...

Continue reading

RemSleep Holdings Inc Announces Engagement of New Investor Relations Firm and News Distributor

Tampa, FL, Jan. 24, 2022 (GLOBE NEWSWIRE) — RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and exposure with current and potential shareholders in conjunction with refining and broadening our overall messaging and outreach. This is in anticipation and because of the overwhelming response from the public and medical field from our pending DeltaWave 510k approval and market release. “We feel we owe it to our current and future investors to have partnered with a gold star firm to assist us with our investor relations moving forward. Maintaining an open line of communication with our shareholders and providing...

Continue reading

Lithium Market to Worth USD 8.24 Billion by 2027 | Global Lithium Industry Growth, Demand, Outlook and Forecast Report by Fortune Business Insights™

companies covered in the lithium market are Tianqi Lithium (Australia), International Lithium Corp. (China), FMC Corporation (India), Albemarle Corporation (U.S.), SQM S.A. (Chile), LSC Lithium Corporation (Canada), American Lithium Corp. (Canada), Livent (U.S.), Avalon Advanced Materials (Canada), Sayona Mining Limited (Australia), and more players profiled Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights™, the global lithium market size is projected to reach USD 8.24 billion by the end of 2027.  The presence of several large scale companies in several countries across the world will emerge in favor of the growth of the global lithium market. Lithium is a chemical element that is present in natural substances such as rocks. The material is approved for use in several industry verticals, including...

Continue reading

North America Sugar-Free Chocolate Market to Reach USD 391.8 Million by 2028 | North America Sugar-Free Chocolate Industry Trends, Growth, and Forecast Report by Fortune Business Insights™

Companies covered in North America sugar-free chocolate market report are The Hershey Company (Pennsylvania, U.S.), Ferrero SpA (Alba, Italy), Chocoladefabriken Lindt & Sprüngli AG (Kilchberg, Switzerland), Godiva Chocolatier (Midtown Manhattan, U.S.), KOHLER Co. (Wisconsin, U.S.), Jackie’s Chocolate (Wisconsin, U.S.), Pascha Chocolate (Toronto, Canada), Pobeda Confectionery Ltd. (Moscow, Russia), Asher’s Chocolate Company (Pennsylvania, U.S.), Barry Callebaut AG (Zürich, Switzerland), and other players profiled Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — The global North America sugar-free chocolate market size is expected to touch USD 391.8 million by 2028, exhibiting a CAGR of 5.42% during the forecast period. The market value stood at USD 242.0 million in 2020 and reached USD 270.7 million in 2021. Increasing health...

Continue reading

Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients

New York, NY, and Tel Aviv, ISRAEL, Jan. 24, 2022 (GLOBE NEWSWIRE) — §  Clinical Data Will be Released Thursday, January 27th, 2022 via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease theragnostic joint venture partner NLC Pharma Ltd., today announced a data lock for the interim data analysis for the Company’s Tollovir™ Phase 2 Clinical Trial for the treatment of hospitalized (severe/critical) COVID-19 patients. The Company will release the results on Thursday, January 27th, 2022. “We are very excited to see the first controlled clinical trial data for Tollovir,” said Dr. Dorit Arad, Founder & Chief Scientific Officer of NLC Pharma, Todos Medical’s 3CL protease biology theragnostics joint venture partner. “We are also...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.